πŸ‡ΊπŸ‡Έ FDA
Patent

US 11286463

Reprogramming of aged adult stem cells

granted A61KA61K35/12

Quick answer

US patent 11286463 (Reprogramming of aged adult stem cells) held by Advanced ReGen Medical Technologies, LLC expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced ReGen Medical Technologies, LLC
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/12